Synthesizes a modified 'retro-inverso' analogue of GHK—where one peptide bond is chemically reversed—to increase enzymatic stability. The analogue showed approximately 10-fold greater resistance to plasma enzyme degradation compared to native GHK, while expected to maintain similar binding properties. Demonstrates a medicinal chemistry approach to improving GHK's therapeutic durability.
Dalpozzo, A; Kanai, K; Kereszturi, G; Calabrese, G